Andrean Bunko, MPH

Consultant
IQVIA Solutions Canada Inc., Canada

Disclosure(s): GlaxoSmithKline Inc.: GSK contracted with IQVIA for this and other projects. I am acting as an author in capacity of my employment with IQVIA.

Poster(s):

• 1252 - A Real-World Observational Study on HIV-Infected Patients who Switched from Nevirapine + 2 Nucleoside Reverse Transcriptase Inhibitors to Dolutegravir/Lamivudine in British Columbia, Canada
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET